Desjardins Global Asset Management Inc. Incyte Corp Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Incyte Corp stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 666 shares of INCY stock, worth $38,181. This represents 0.0% of its overall portfolio holdings.
Number of Shares
666
Previous 657
1.37%
Holding current value
$38,181
Previous $37,000
10.81%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding INCY
# of Institutions
618Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.07 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.33 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.3 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$884 Million0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$568 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $12.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...